These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25932262)

  • 21. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.
    Chedid V; Dhalla S; Clarke JO; Roland BC; Dunbar KB; Koh J; Justino E; Tomakin E; Mullin GE
    Glob Adv Health Med; 2014 May; 3(3):16-24. PubMed ID: 24891990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis.
    Luo M; Li L; Yang EN; Cao WK
    Hepatol Res; 2012 Dec; 42(12):1202-10. PubMed ID: 22646055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial.
    Mousa N; Abdel-Razik A; Zaher A; Hamed M; Shiha G; Effat N; Elbaz S; Elhelaly R; Hafez M; El-Wakeel N; Eldars W
    Therap Adv Gastroenterol; 2016 Sep; 9(5):684-91. PubMed ID: 27582881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.
    Furnari M; De Alessandri A; Cresta F; Haupt M; Bassi M; Calvi A; Haupt R; Bodini G; Ahmed I; Bagnasco F; Giannini EG; Casciaro R
    J Gastroenterol; 2019 Mar; 54(3):261-270. PubMed ID: 30232597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial).
    Janyajirawong R; Vilaichone RK; Sethasine S
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2879-2887. PubMed ID: 34582657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients.
    Fiorillo A; Gallego JJ; Casanova-Ferrer F; Urios A; Ballester MP; San Miguel T; Megías J; Kosenko E; Tosca J; Rios MP; Escudero-García D; Montoliu C
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study).
    Guo H; Lu S; Zhang J; Chen C; Du Y; Wang K; Duan L
    Front Pharmacol; 2023; 14():1121435. PubMed ID: 36873985
    [No Abstract]   [Full Text] [Related]  

  • 29. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
    Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Trimebutine and Rifaximin on Breath Hydrogen and Methane by Glucose Breath Test in Patients With Functional Bloating: A Randomized Double-blind Clinical Trial.
    Jo IH; Paik CN; Lee JM; Song DS; Kim YJ
    J Neurogastroenterol Motil; 2024 Apr; 30(2):220-228. PubMed ID: 38576371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
    Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
    Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and treatment of small intestinal bacterial overgrowth in postoperative patients with colorectal cancer.
    Deng L; Liu Y; Zhang D; Li Y; Xu L
    Mol Clin Oncol; 2016 May; 4(5):883-887. PubMed ID: 27123301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
    Sidhu SS; Goyal O; Parker RA; Kishore H; Sood A
    Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
    Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
    Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care.
    DE Bastiani R; Lopetuso LR; DE Bastiani M; Bacchin P; Benedetto E; Boscariolo L; Caneve R; Chesani F; Chiumeo F; Civic Z; Dainese A; DE Polo M; Disclafani G; Grattagliano I; Mana O; Mancuso M; Mastronuzzi T; Pati A; Pirrotta E; Salandini M; Sanna G; Scoglio R; Severino P; Tosetti C; Turnava L; Zamparella M; Elisei W; Gasbarrini A; Tursi A
    Minerva Gastroenterol (Torino); 2023 Dec; 69(4):523-528. PubMed ID: 36943203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy.
    Rai R; Ahuja CK; Agrawal S; Kalra N; Duseja A; Khandelwal N; Chawla Y; Dhiman RK
    Clin Transl Gastroenterol; 2015 Sep; 6(9):e111. PubMed ID: 26378384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression-based Chinese norms of number connection test A and digit symbol test for diagnosing minimal hepatic encephalopathy.
    Zhang P; Gan D; Chi X; Mao D; Gao Y; Li Y; Zhou D; Li Q; Zhang M; Lu B; Li F; Xue J; Wang X; Du H; Li X; Liang Y; Ye Y
    Sci Rep; 2024 Feb; 14(1):4005. PubMed ID: 38369632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea.
    Jeong JY; Jun DW; Bai D; Kim JY; Sohn JH; Ahn SB; Kim SG; Kim TY; Kim HS; Jeong SW; Cho YK; Song DS; Kim HY; Jung YK; Yoon EL
    J Korean Med Sci; 2017 Sep; 32(9):1484-1490. PubMed ID: 28776344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.